9:41
metagenomi.co
Screenshot of metagenomi.co
metagenomi.co favicon

metagenomi.co

9 technologies
VerifiedVisit5.1K/mo$51M2659 Tech25 Leads
Deep Dive

Metagenomi: The $376M Bet on In Vivo Gene Editing

How a stealthy biotech is building the next generation of genetic medicines with a $51M revenue engine

While most gene editing startups are still optimizing CRISPR in petri dishes, Metagenomi is already engineering human cells inside the body. With $376M in funding and a $51M revenue engine, they're not just playing the gene editing game—they're rewriting the rules of in vivo therapeutics.

$376M
Total Funding
$51.3M
Annual Revenue
265
Employees
45%
Direct Traffic

"Metagenomi isn't just editing genes—they're building a platform that could make ex vivo cell therapy obsolete for certain diseases."

The In Vivo Advantage

Unlike competitors focused on ex vivo approaches (where cells are edited outside the body), Metagenomi's proprietary technology enables direct in vivo editing. This means potentially simpler manufacturing, lower costs, and broader patient accessibility. Their 265-person team is capitalizing on this with a pipeline targeting liver diseases, blood disorders, and more.

The Traffic Tells a Story

With 5,136 monthly visits and a #3.4M global rank, Metagenomi isn't chasing mass-market traffic—this is pure investor and industry attention. The 89.9% 'undefined' traffic likely represents institutional investors and biotech professionals accessing their portal, while 45% direct traffic shows strong brand recall among insiders.

  • Proprietary enzyme discovery platform mining novel microbial genomes
  • Focus on in vivo editing to bypass complex cell manufacturing
  • $51M revenue indicates active partnerships or early-stage commercialization
  • 265 employees suggests rapid scaling toward clinical trials
Doesn't chase consumer gene editing hype
Targets serious diseases with unmet need
Avoids the crowded ex vivo cell therapy space
Builds platform for multiple therapeutic areas
No flashy direct-to-consumer marketing
Partners with pharma for commercialization

The keyword data reveals their strategic positioning. While 'mgx' gets 34,450 monthly searches (likely ticker-related), 'metagenomi stock today' shows investors are actively tracking them. This isn't a company building for buzz—they're building for institutional validation and eventual IPO or acquisition.

The Platform Play in a $10B+ Market

With $376M raised and $51M in revenue, Metagenomi is positioned as the infrastructure layer for the next generation of genetic medicines—not just another one-disease biotech.

What tech stack does Metagenomi use?

12 detected
Media1
Security1
Cloud & Hosting1
Analytics & Marketing1
Web Standards2
UI Libraries1
Tracking & Analytics3
G
Google Analytics
G
Google Tag Manager
G
Google Analytics

How much traffic does Metagenomi get?

Traffic & Engagement

5.1K
Monthly Visits
2.0
Pages/Visit
0:38
Avg. Duration
40%
Bounce Rate
Monthly Traffic Trend-14%
6.0K
Oct 2025
Oct
5.4K
Nov 2025
Nov
5.1K
Dec 2025
Dec

Traffic Sources

Search
37%
Direct
45%
Social
10%
Referrals
6%
Email
0%
Paid
1%

Where is Metagenomi's audience located?

🌍89.9%
🌍10.1%

What keywords does Metagenomi rank for?

5 keywords
1metagenomi890 vol$4.16
2mgx filings190 vol
3metagenomi stock today950 vol
4mgx34.5K vol$2.06
5allan brooks870 vol

How is Metagenomi's SEO?

Open Graph Image

OG Image preview
og:image

https://metagenomi.imgix.net/metagenomi-seo-image.png?auto=compress%2Cformat&crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=630&q=60&w=1200&s=dcdcd18b56fbe733f9ccf2ad0dd474dd

Meta Tags

title64 chars

Metagenomi | The Evolution of Genome Editing to Create Curative…

description143 chars

Metagenomi is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients.

languageEN-US

H1 Tags

h1Home

Schema Types

Unknown

Who works at Metagenomi?

Loading leads...

What do customers think of Metagenomi?

No Trustpilot reviews available for this company.

Frequently Asked Questions about Metagenomi

What is Metagenomi's Revenue?
Metagenomi generates approximately $51M in annual revenue. With 265 employees, that's $193,750 per employee. The company has raised $376M in total funding.
What does Metagenomi do?
Metagenomi is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients.
How fast is Metagenomi growing?
Metagenomi employee count has changed by -17% year over year.
What technologies does Metagenomi use?
Metagenomi uses 9 technologies across their website including Media, Security, Cloud & Hosting. Key technologies include imgix, HSTS, Cloudflare.
Who are Metagenomi's competitors?
Metagenomi's main competitors include DiaCarta, Mission Bio, Quadrants Scientific, Calcilytix Therapeutics, Ravata Solutions. These companies operate in similar markets and compete for the same customer base.

Export Data

Unlock all exports

Download CSVs, JSONs & full reports

What are Metagenomi's key pages?

Export metagenomi.co Data

Download the complete tech stack, analytics, leads, and company data for metagenomi.co in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.

Raw JSON Data

Click "Show" to view the raw API response data

About metagenomi.co

Metagenomi is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients.

Company Overview

metagenomi.co
Website
health
Industry
#3,449,082
Global Rank
5.1K
Monthly Visitors
9
Technologies
25+
Employees

metagenomi.co Key Pages

metagenomi.co Social Media

Technology Stack

metagenomi.co uses 9 technologies across their website including imgix, HSTS, Cloudflare, and more.

Media

imgix

Security

HSTS

Cloud & Hosting

Cloudflare

Analytics & Marketing

Google Analytics

Web Standards

Twitter Cards, PWA

UI Libraries

DaisyUI

Traffic & Audience

5.1K
Monthly Visits
40%
Bounce Rate
2.0
Pages/Visit
0:38
Avg. Duration

metagenomi.co receives approximately 5.1K monthly visitors and ranks #3,449,082 globally. The website has a bounce rate of 40% with visitors viewing an average of 2.0 pages per visit. Users spend an average of 0:38 on the site.

The majority of metagenomi.co's traffic comes from undefined, .

Frequently Asked Questions

What is metagenomi.co?
Metagenomi is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients.
What technologies does metagenomi.co use?
metagenomi.co uses 9 technologies including imgix, HSTS, and 3 more. View the full tech stack analysis above.
How do I contact metagenomi.co?
You can contact metagenomi.co via email at [email protected].
What are metagenomi.co's social media accounts?
metagenomi.co is active on linkedin. You can find links to all their social media profiles in the social section above.
Is metagenomi.co hiring?
Check metagenomi.co's careers page for current job openings and opportunities. The company has 25+ known employees.
How popular is metagenomi.co?
metagenomi.co receives approximately 5.1K monthly visitors and ranks #3,449,082 globally. Traffic is declining by 4.9% month-over-month.

Related Searches

metagenomi.co pricingmetagenomi.co reviewsmetagenomi.co alternativesmetagenomi.co loginmetagenomi.co careerswhat is metagenomi.cometagenomi.co tech stackmetagenomi.co contactmetagenomi.co vs competitorsmetagenomi.co featureshow to use metagenomi.cometagenomi.co integrations

This page provides publicly available information about metagenomi.co. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit metagenomi.co directly at https://metagenomi.co.